From: Evaluating the quality of routinely reported data on malaria commodity stocks in Guinea, 2014–2016
Commodity | Number of reports | ||
---|---|---|---|
< 25% difference | 25–50% difference | > 50% difference | |
RDT | 37/92 (40%) | 15/92 (16%) | 40/92 (43%) |
ASAQ infant | 47/93 (51%) | 11/93 (12%) | 35/93 (38%) |
ASAQ small child | 47/99 (47%) | 13/99 (13%) | 39/99 (39%) |
ASAQ child | 44/102 (43%) | 17/102 (17%) | 41/102 (40%) |
ASAQ adult | 40/98 (41%) | 22/98 (22%) | 36/98 (37%) |
AL | 4/15 (27%) | 4/15 (27%) | 7/15 (47%) |
SP | 40/98 (41%) | 17/98 (17%) | 41/98 (42%) |
Injectable artesunate | 4/9 (44%) | 2/9 (22%) | 3/9 (33%) |
Injectable artemether | 4/10 (40%) | 0/10 (0%) | 6/10 (60%) |
Injectable quinine | 31/74 (42%) | 18/74 (24%) | 25/74 (34%) |
Quinine tablets | 20/53 (38%) | 6/53 (11%) | 27/53 (51%) |
LLIN | 25/53 (47%) | 11/53 (21%) | 17/53 (32%) |